Key result
Platelet distribution width was significantly higher in patients with acute coronary syndrome compared to healthy controls (p=0.000), but could not be used to predict patient outcomes or length of stay.
Why the study?
Does platelet distribution width (PDW) differ between ACS patients and controls, and can it predict patient outcome and length of stay?
Cross-Sectional (n=232)
No
Does platelet distribution width (PDW) differ between ACS patients and controls, and can it predict patient outcome and length of stay?
Absolute Event Rate: 11.1% vs 10.05%
p-value: p=0.000
Platelet distribution width is elevated in acute coronary syndrome compared to normal controls but does not appear to predict mortality or length of hospital stay.
PDW elevation may aid ACS identification but not prognosis; leaves open independent predictive value in prospective studies.
An acute coronary syndrome is a form of clinical manifestation of coronary heart disease with atherosclerosis, and thrombosis processes. Platelets play an essential role in thrombosis. High PDW shows a variation of the morphology, and size of a platelet. This was a retrospective cross-sectional study comparing PDW, length of stay, and patient outcome in STEMI, NSTEMI, UAP, and control patients at the Dr.Wahidin Sudirohusodo Hospital Makassar during the period of January 2014 – December 2015. Data were analyzed using statistical software. One hundred, and seventy-two ACS patients were included; 65 patients had UAP, 48 patients had STEMI and 59 patients had NSTEMI. Sixty normal patients were included as a control. Kruskal-Wallis test showed a statistical difference in PDW between patients with STEMI, NSTEMI, UAP, and control (p=0.000). Post hoc test showed a significant difference between ACS, and control, STEMI, and control (p=0.000), NSTEMI and control (p=0.000), UAP, and control (p=0.000), but there no significant difference between STEMI, and NSTEMI (p=0.320), STEMI, and UAP (p=0.980), NSTEMI and UAP (p=0.435). There was no significant difference in PDW between patients who survived, and died (p=0.298), and also patients with a length of stay of ≤ 7 days, and > 7 days (p=0.293). Platelet distribution width was higher in ACS patients compared with control patients, but could not be used to predict the outcome, and length of stay of patients with ACS. It is advisable to do further research with a large sample size to avoid bias.
No takes yet. Share an insight, caveat, or question.
Latif et al. (2018) conducted a cross-sectional in Acute Coronary Syndrome (n=232). Acute Coronary Syndrome vs. Healthy controls was evaluated on Platelet Distribution Width (PDW) (p=0.000). Platelet distribution width was significantly higher in patients with acute coronary syndrome compared to healthy controls (p=0.000), but could not be used to predict patient outcomes or length of stay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: